- Raised $3M funding round, Sep 2023
- Raised $3.1M grant, Jul 2017
- Raised $100k grant, Aug 2014
About
Carmel Diagnostics has developed a method for measuring the oxidative stress (OS) of biological liquids, a recognized biomarker of health and disease and a key diagnostics parameter. This OS parameter is measured using thermochemiluminescence (TCL) technology. The company's lead product is focused on the process of embryo selection in in-vitro fertilization (IVF). The Fertissimo TCL Analyzer is a noninvasive embryo selection system for the IVF market, offering up to a 20% increase in successful IVF pregnancies. Effective embryo viability assessment significantly improves the success rate and reduces the risk of multiple births. Carmel Diagnostics has performed two successful proof-of-concept studies covered by peer-reviewed articles on the applications of risk stratification for patients with congestive heart failure and embryo selection in the IVF process, and is currently performing a clinical validation study for the IVF application. Carmel Diagnostics was awarded a Horizon 2020 phase-2 grant.
Funding history · 5 rounds · $6.9M total
Q&A
- What is Carmel Diagnostics' primary focus?
- Carmel Diagnostics focuses on measuring oxidative stress in biological liquids using thermochemiluminescence (TCL) technology, with a lead product, the Fertissimo TCL Analyzer, aimed at embryo selection in in-vitro fertilization (IVF).
- What is the current employee count for Carmel Diagnostics?
- Carmel Diagnostics has 1-10 employees.
- When was Carmel Diagnostics founded?
- Carmel Diagnostics was founded in January 2009.
- What is the total amount of funding Carmel Diagnostics has raised to date?
- Carmel Diagnostics has raised a total of $6,940,000 USD.
- When did Carmel Diagnostics receive its most recent funding?
- Carmel Diagnostics received $3,000,000 USD in September 2023.
- Which organization provided a grant to Carmel Diagnostics in July 2017?
- In July 2017, Carmel Diagnostics received a grant of $3,070,000 USD from EU Horizon 2020.
- What is the current product stage of Carmel Diagnostics?
- Carmel Diagnostics' product is currently in the clinical trial stage.
- Who are the founders of Carmel Diagnostics?
- The founders of Carmel Diagnostics are Cnaani Tzali, who serves as Founder & CEO, and Sergei Shnizer, who is the Co-founder & CTO.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | carmel-diagnostics.com |
|---|---|
| linkedin.com/company/1558211 | |
| facebook.com/Carmel-Diagnostics-1682162225237831 | |
| YouTube | youtube.com/channel/UCXo7DRLIHS7Vih_H-DDyOhQ |
Identifiers & details
| Former names | Lumitest |
|---|---|
| Founded | 2009-1 |
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | carmel-diagnostics.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|